Ron Squarer, Chief

2013

In 2013, Ron Squarer, Chief earned a total compensation of $2.4M as Executive Officer at Array BioPharma, a 1% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$329,725
Option Awards$1,275,853
Salary$528,192
Other$246,976
Total$2,380,746

Chief received $1.3M in option awards, accounting for 54% of the total pay in 2013.

Chief also received $329.7K in non-equity incentive plan, $528.2K in salary and $247K in other compensation.

Rankings

In 2013, Ron Squarer, Chief's compensation ranked 3,284th out of 12,286 executives tracked by ExecPay. In other words, Chief earned more than 73.3% of executives.

ClassificationRankingPercentile
All
3,284
out of 12,286
73rd
Division
Manufacturing
1,113
out of 4,612
76th
Major group
Chemicals And Allied Products
293
out of 1,462
80th
Industry group
Drugs
200
out of 1,156
83rd
Industry
Pharmaceutical Preparations
166
out of 890
81st
Source: SEC filing on September 13, 2013.

Chief's colleagues

We found seven more compensation records of executives who worked with Ron Squarer, Chief at Array BioPharma in 2013.

2013

Ron Squarer

Array BioPharma

Chief Executive Officer

2013

Andrew Robbins

Array BioPharma

Chief Operating Officer

2013

Michael Needle

Array BioPharma

Chief Medical Officer

2013

Kevin Koch

Array BioPharma

Chief Scientific Officer

2013

David Snitman

Array BioPharma

Chief Operating Officer

2013

R Carruthers

Array BioPharma

Chief Financial Officer

2013

John Moore

Array BioPharma

General Counsel

In-depth

You may also like